Percentage of patients continuing to take none, 200 mg, or 400 mg of thalidomide or placebo
| . | 30 days . | 90 days . | 1 year . | |||
|---|---|---|---|---|---|---|
| MPT, percentage . | MP, percentage . | MPT, percentage . | MP, percentage . | MPT, percentage . | MP, percentage . | |
| Stopped therapy | 22 | 9 | 32 | 11 | 56 | 33 |
| Less than 200 mg | 8 | 5 | 12 | 5 | 12 | 6 |
| 200 mg | 41 | 44 | 33 | 30 | 25 | 39 |
| 400 mg | 29 | 42 | 23 | 54 | 7 | 22 |
| No. of patients evaluated | 170 | 167 | 152 | 156 | 109 | 100 |
| . | 30 days . | 90 days . | 1 year . | |||
|---|---|---|---|---|---|---|
| MPT, percentage . | MP, percentage . | MPT, percentage . | MP, percentage . | MPT, percentage . | MP, percentage . | |
| Stopped therapy | 22 | 9 | 32 | 11 | 56 | 33 |
| Less than 200 mg | 8 | 5 | 12 | 5 | 12 | 6 |
| 200 mg | 41 | 44 | 33 | 30 | 25 | 39 |
| 400 mg | 29 | 42 | 23 | 54 | 7 | 22 |
| No. of patients evaluated | 170 | 167 | 152 | 156 | 109 | 100 |
Patients who died or relapsed before the indicated time point are excluded from the analysis.